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Abstract
Several studies suggest that 50-kHz ultrasonic vocalizations (USVs) may indicate a positive affective state in rats,
and these vocalizations are increasingly being used to investigate the properties of psychoactive drugs. Previous
studies, however, have focused on dopaminergic psychostimulants and morphine, whereas little is known
about how other drugs modulate 50-kHz USVs. To further elucidate the neuropharmacology of 50-kHz USVs,
the present study characterized the direct and long-lasting effects of different drugs of abuse, by measuring
the number of 50-kHz USVs and their ‘trill’ subtype emitted by adult male rats. Rats received repeated
administrations of amphetamine (2mg/kg, i.p.), 3,4-methylenedioxymethamphetamine (MDMA, 7.5mg/kg,
i.p.), morphine (7.5mg/kg, s.c.), or nicotine (0.4mg/kg, s.c.), on either consecutive or alternate days (ﬁve
administrations in total) in a novel environment. Seven days later, rats were re-exposed to the drug-paired
environment, subjected to USVs recording, and then challenged with the same drug. Finally, 7 d after the
challenge, rats were repeatedly exposed to the drug-paired environment and vocalizations were measured.
Amphetamine was the only drug to stimulate 50-kHz USVs and ‘trill’ subtype emission during administration
and challenge. Conversely, all rats emitted 50-kHz USVs when re-exposed to the test cage, and this effect was
most marked in morphine-treated rats, and less evident in nicotine-treated rats. This study demonstrates
that the direct and long-lasting effects of drugs on 50-kHz USVs are regulated differently, providing a better
understanding of the usefulness of these vocalizations in the study of psychoactive drugs.
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Introduction
Rats emit ultrasonic vocalizations (USVs) in response to
a wide range of stimuli, and a link between USVs and
emotional state has been suggested (Knutson et al.,
2002; Covington and Miczek, 2003; Panksepp, 2005;
Wöhr et al., 2005; Brudzynski, 2007, 2013; Schwarting
et al., 2007; Willey and Spear, 2013). In this regard, it
has been proposed that the so-called ‘50-kHz’ USVs,
with a frequency range of 35–90 kHz (Portfors, 2007), in-
dicate a positive effect, as they are preferentially emitted
in response to, or in anticipation of, pleasurable stimuli,
such as mating and non-aggressive social encounters
(Knutson et al., 1999; Brudzynski, 2005; Burgdorf et al.,
2008, 2011). Interestingly, 50-kHz USVs can also be
observed following the administration of rewarding
drugs (Wintink and Brudzynski, 2001; Mu et al., 2009;
Simola et al., 2012). Accordingly, independent investiga-
tions have suggested that 50-kHz USVs emission may
be a straightforward tool to study the effects of drugs
on affect and motivation (Ahrens et al., 2009; Mu et al.,
2009; Williams and Undieh, 2010; Hamed et al., 2012).
Although this hypothesis is intriguing, previous studies
by us and others have demonstrated that drugs of abuse
may have different effects on 50-kHz USVs. Investigations
using acute drug administration found that the dopami-
nergic psychostimulants amphetamine, cocaine, and
methylphenidate signiﬁcantly stimulated 50-kHz USVs,
whereas caffeine, 3,4-methylenedioxymethamphetamine
(MDMA, ‘ecstasy’), morphine, and nicotine did not
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(Wintink and Brudzynski, 2001; Simola et al., 2010,
2012; Williams and Undieh, 2010; Sadananda et al.,
2012). Conﬂicting results have also been obtained by
studies using repeated drug administration. Thus, a pro-
gressive increase in 50-kHz USVs emission has been
observed in rats treated with amphetamine or cocaine
(Ahrens et al., 2009; Mu et al., 2009). Conversely, others
found mixed effects of amphetamine and no effect of mor-
phine (Taracha et al., 2012; Wright et al., 2012). Moreover,
little is known about the effects of repeated administration
of drugs other than dopaminergic psychostimulants and
morphine on 50-kHz USVs modulation, and further char-
acterization of this is required. Importantly, investigations
should be done under comparable conditions, to avoid
potential confounding factors related to differences in
the experimental procedures used.
This study evaluated USVs emissions in rats subjected
to repeated treatment (ﬁve administrations) with amphe-
tamine, MDMA, morphine, or nicotine. USVs elicited
on drug treatment and challenge, administered 7 d after
drug discontinuation, were recorded, together with
USVs, emitted on re-exposure to the drug-paired environ-
ment. To ascertain the effects of drug administration
protocol on USVs, rats received drugs on either consecu-
tive or alternate days. Moreover, as different subtypes of
50-kHz USVs exist and ‘trill’ vocalizations are envisioned
as those most closely linked to pleasurable stimuli
(Burgdorf et al., 2008; Ahrens et al., 2009; Wright et al.,
2010), modiﬁcations involving ‘trill’ USVs, either stimu-
lated by drugs or emitted on test cage re-exposure were
evaluated. This approach was used to characterize the
effects of different drugs of abuse on 50-kHz USVs, and
to gain further insight into the relevance of these vocaliz-
ations in the study of psychoactive drugs.
Method
Subjects
Male Sprague–Dawley rats (Harlan, Italy) weighing
275–300 g were used. Rats were housed in groups of
four or ﬁve in standard polycarbonate cages with saw-
dust bedding, and maintained on a 12-h light/dark cycle
(lights on at 08:00 h). Rats had free access to food
(standard laboratory chow) and tap water, except during
the experiments, which took place from 10:00 to 15:00 h.
All experiments were conducted in accordance with
the guidelines for care and use of experimental animals
of the EU directives (2010/63/EU; L.276; 22/09/2010), and
with the guidelines approved by the Ethical Committee
of the University of Cagliari. Efforts were made to mini-
mize the number of animals used and maximize humane
treatment.
Drugs
D-Amphetamine (sulfate) and nicotine (bitartrate) were
purchased from Sigma–Aldrich (Italy). MDMA was
synthesized at the Department of Life and Environmental
Sciences of the University of Cagliari, as described else-
where (Frau et al., 2013). Morphine (hydrochloride) was
purchased from Franchini Prodotti Chimici srl (Italy).
All drugs were dissolved in distilled water. Morphine
(7.5 mg/kg) and nicotine (0.4 mg/kg) were injected subcu-
taneously (s.c.), in a volume of 1ml/kg. Nicotine solutions
were neutralized with NaOH (1N) before being adminis-
tered (ﬁnal pH=7). Amphetamine (2mg/kg) and MDMA
(7.5mg/kg) were administered intraperitoneally (i.p.), in a
volume of 3ml/kg. The doses of the drugs used in this
study were selected based on our previous study evalu-
ating the acute effects of the same drugs (Simola et al.,
2012), and on preliminary experiments showing that re-
peated administration of MDMA, morphine, or nicotine
at doses lower than those used here failed to signiﬁcantly
stimulate 50-kHz USVs in rats.
Experimental procedure
The experiments were designed based on our previous
studies (Simola et al., 2010, 2012). Rats were handled
daily (5 min) for 2 d before experimentation. Experiments
consisted of seven phases: (1) habituation to the test cage;
(2) acute administration of vehicle in the test cage, to
quantify basal USVs; (3) repeated drug or vehicle admin-
istration in the test cage on either consecutive or alternate
days (ﬁve administrations in total), and USVs recording
on ﬁrst and ﬁfth administration; (4) drug withdrawal
in the home cage; (5) evaluation of USVs elicited by
test cage re-exposure, followed by drug challenge and
recording of drug-stimulated USVs; (6) drug withdrawal
in the home cage; (7) repeated test cage re-exposure to
evaluate the persistence and extinction of USVs. Loco-
motor activity was measured throughout the experi-
ments by means of automated counters (Opto-Varimex;
Columbus Instruments, Columbus, OH, USA). Figure 1
shows the experimental plan. An intermittent adminis-
tration regimen was employed to attenuate the emerg-
ence of tolerance (Simola et al., 2006), and evaluate
whether the administration protocol may inﬂuence the ef-
fects of drugs on USVs. Separate groups of rats were trea-
ted with amphetamine (2mg/kg, i.p.), MDMA (7.5 mg/kg,
i.p.), morphine (7.5 mg/kg, s.c.), or nicotine (0.4 mg/kg,
s.c.). Rats were randomly assigned to an experimental
group, and vehicle-treated rats served as controls. Groups
were composed as follows: amphetamine, n=6/6; MDMA,
n=6/7; morphine, n=8/8; nicotine, n=6/6; vehicle, n=6/6,
where n represents the number of rats receiving the
drug in consecutive/alternate administration.
USVs recording
USVs recording took place in a quiet room. Each rat
was individually placed in a Plexiglas cylinder (diameter,
25 cm; height, 30 cm) enclosed by four cardboard walls
(height, 65 cm; distance from the cylinder, 15 cm). The
bottom of the cylinder was covered with sawdust taken
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from the individual rat home cage, to attenuate the inﬂu-
ence of a novel environment on USVs emission (Natusch
and Schwarting, 2010). The cylinder was covered with
a lid equipped with an ultrasonic microphone bearing
high directional properties (CM16/CMPA, Avisoft,
Germany), and connected to an ultrasound-recording
device (UltraSoundGate 116Hb, Avisoft, Germany).
During recordings, intensity gain was kept at the same
level for all the rats. USVs stimulated by either drug or
vehicle were recorded for 1 h, whereas USVs emitted
on re-exposure to the drug-paired environment were
recorded for 10min (Fig. 1).
Vocalizations emitted by morphine-treated rats on
test cage re-exposure
Rats receiving morphine on alternate days exhibited
a pronounced and long-lasting emission of 50-kHz
USVs on test cage re-exposure. Therefore, an additional
group of morphine-treated rats was employed to ascertain
the conditioned nature of these vocalizations. Rats (n=6)
received four morphine administrations (7.5 mg/kg. s.c.)
in the home cage, alternating with four vehicle adminis-
trations in the test cage. The day after the last vehicle ad-
ministration, rats received a ﬁfth morphine administration
in the test cage, and drug-stimulated USVs were recorded.
USVs emitted on test cage re-exposure were measured 7 d
later; afterwards these rats underwent drug challenge and
USVs extinction.
Data collection, analysis, and statistics
The software SASLab Pro 4.52 (Avisoft, Germany) was
used to convert USVs recordings into spectrograms
with these settings: 512 FFT-length, Hamming window,
and 75% overlap frame set-up (Wöhr and Schwarting,
2009; Simola et al., 2012). Spectrograms were visually
inspected by an experienced experimenter, then pro-
cessed as described elsewhere (Simola et al., 2012). After
manual cleaning of all signals that could not be univo-
cally classiﬁed as vocalizations, the number of 50-kHz
USVs was calculated by SASLab Pro 4.52. For classiﬁ-
cation of ‘trill’ 50-kHz USVs, each spectrogram was visu-
ally inspected three times, separated by a 7-d interval.
USVs that were not uniformly classiﬁed over the three
evaluations were discarded. USVs were classiﬁed as
‘trill’ vocalizations according to Wright et al. (2010)
(Fig. 2). The present study observed similar emissions of
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Fig. 2. Example of sonograms of 50-kHz ultrasonic
vocalizations (USVs).
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drug-stimulated 50-kHz USVs in rats administered drugs
on consecutive and alternate days. Conversely, only the
latter rats displayed a signiﬁcant emission of 50-kHz
USVs when re-exposed to the test cage. Therefore, to com-
pare the direct and long-lasting effects of drugs, analysis
of ‘trill’ 50-kHz USVs was narrowed to rats treated on
alternate days. USVs data obtained in the present study
were found to be normally distributed, therefore para-
metric statistics were employed. Means±S.E.M. of the num-
ber of total and ‘trill’ 50-kHz USVs, of the percentage of
‘trill’ USVs (over total USVs), and of locomotor activity
counts were calculated. Time-course evaluation of drug-
stimulated 50-kHz USVs was also performed. Data were
analyzed by means of two-tailed Student’s t test, two-way
(treatment×day), or three-way (treatment×day×time),
analysis of variance (ANOVA), followed by Tukey’s post-
hoc test when appropriate. Signiﬁcance was set at p<0.05
for each analysis. Statistical analysis was performed with
Statistica for Windows (StatSoft, USA).
Results
Effect of drugs and re-exposure to the test cage on
locomotor activity
The doses of amphetamine, MDMA, and nicotine used in
this study signiﬁcantly stimulated locomotor activity,
compared with vehicle administration. The dose of mor-
phine used in this study did not elicit motor suppression
(except on the ﬁrst administration) and sedation. When
re-exposed to the test cage at 7 d from drug discontinu-
ation, rats treated on alternate days displayed a signiﬁ-
cantly higher locomotor activity than vehicle-treated
rats, and this was evident for all the drugs evaluated
(Table 1). This was no longer present 7 d after drug chal-
lenge (data not shown).
Emission of 50-kHz USVs stimulated by acute vehicle,
and emission of 22-kHz USVs
Acute vehicle administration 1 d before drug treatments
scarcely stimulated 50-kHz USVs and locomotion, with
no differences among the experimental groups (data not
shown). Moreover, 22-kHz USVs, which are thought to
reﬂect negative affective states (Brudzynski, 2007), were
emitted by two rats administered nicotine, and one admi-
nistered amphetamine, which were excluded from the
analysis.
Emission of 50-kHz USVs stimulated by repeated drug
administration
Amphetamine
Rats repeatedly treated with amphetamine (2mg/kg, i.p.),
on either consecutive or alternate days, emitted signiﬁ-
cantly more 50-kHz USVs than vehicle-treated rats
(Fig. 3a). Two-way ANOVA for consecutive-day
amphetamine revealed an effect of treatment (F1,10 =
12.42, p=0.03), but no effect of day (F1,10 =0.31, p=0.26),
and no treatment×day interaction (F1,10=1.23, p=0.25).
Table 1. Locomotor activity measured during drug treatment and re-exposure to the test cage. Locomotor activity counts measured in
rats that received repeated treatment with amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), morphine, or nicotine on
consecutive days (upper panel) and on alternate days (lower panel). Locomotor activity counts were measured during the ﬁrst and ﬁfth
drug administration, on re-exposure to the test cage immediately before drug challenge, and after drug challenge
Locomotor activity counts after drug treatment on consecutive days and challenge
Treatment First administration Fifth administration Drug challenge Re-exp. to the drug-paired environment
Amphetamine 4678.5±514.6* 7354.5±719.6* 6681±751.1* 711±61.5*
MDMA 7366.7±1030.6* 5543.8±447.1* 6389.5±728.9* 538.7±65.8
Morphine 483±135.8* 645.8±136 525.5±92.1 518.1±39.6
Nicotine 1167.7±174* 1956.3±156.9* 1705±141.2* 457.7±76.7
Vehicle 851±139.8 666.2±104.2 613.8±54.2 464.7±69.3
Locomotor activity counts after drug treatment on alternate days and challenge
Treatment First administration Fifth administration Challenge Re-exp. to the drug-paired environment
Amphetamine 4839.2±587.3* 7770.7±901.9* 6253.2±668.4* 717±92.7*
MDMA 4789±218.4* 4040±447.3* 5187.4±472.2* 575.4±34.4*
Morphine 177.4±36* 676±72.2 602±62.2 581±29.5*
Nicotine 1080.2±103.4* 1683.3±194.7* 1357±187.8* 568.8±35.5*
Vehicle 669±172.8 887±130.4 592.8±55.1 422.7±43.2
MDMA=3,4-methylenedioxymethamphetamine; re-exp.=re-exposure.
* p<0.05 compared with vehicle-treated rats.
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Similarly, two-way ANOVA for alternate-day ampheta-
mine showed an effect of treatment (F1,10 =11.37
p=0.01), but no effect of day (F1,10 =1.18, p=0.30), and
no treatment×day interaction (F1,10 =1.59, p=0.23). No
signiﬁcant differences in 50-kHz USVs emissions were
observed between rats administered amphetamine on
consecutive or alternate days (Fig. 3a, Supplementary
Table S1).
MDMA
Repeated MDMA (7.5mg/kg, i.p.) administration, on
either consecutive or alternate days, stimulated 50-kHz
USVs emissions similar to that recorded in vehicle-treated
rats. The 50-kHz USVs emissions of MDMA-treated rats
were similar for consecutive- and alternate-day adminis-
tration (Fig. 3b, Supplementary Table S1).
Morphine
Rats repeatedly treated with morphine (7.5 mg/kg, s.c.)
showed an emission of 50-kHz USVs not signiﬁcantly
different from that of vehicle-treated rats. Nevertheless,
signiﬁcant modiﬁcations in morphine-stimulated vocali-
zations occurred during drug administration (Fig. 3c).
Two-way ANOVA for consecutive-day morphine re-
vealed no effect of treatment (F1,12 =0.13, p=0.72), but
showed an effect of day (F1,12=4.63, p=0.04), and a treat-
ment×day interaction (F1,12 =7.06, p=0.02). As for
alternate-day morphine, two-way ANOVA indicated
no effect of treatment (F1,12=0.02, p=0.90), and no
treatment×day interaction (F1,12=0.53, p=0.47), but
revealed an effect of day (F1,12 =7.87, p=0.02). Tukey’s
post-hoc test showed that rats treated with morphine on
either consecutive or alternate days emitted signiﬁcantly
more 50-kHz USVs on the ﬁfth drug administration.
When 50-kHz USVs emissions of rats treated with
morphine on consecutive days and alternate days were
compared, two-way ANOVA showed an effect of
day (F1,14 =15.5, p=0.01), but no effect of treatment
(F1,14=0.51, p=0.49), and no treatment×day interaction
(F1,14=0.57, p=0.46) (Fig. 3c).
Nicotine
Repeated treatment with nicotine (0.4 mg/kg, s.c.), on
either consecutive or alternate days, stimulated 50-kHz
USVs emissions similar to that observed in vehicle-treated
rats. This effect was comparable between rats receiving
nicotine on consecutive and alternate days (Fig. 3d,
Supplementary Table S1).
Emission of 50-kHz USVs following re-exposure to
the drug-paired environment or drug challenge
Amphetamine
On test cage re-exposure 7 d after treatment discontinu-
ation, rats repeatedly treated with amphetamine on con-
secutive days displayed an emission of 50-kHz USVs
not signiﬁcantly different from that of vehicle-treated
rats, although a trend towards an increase in this effect
was present. Conversely, rats repeatedly treated with
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Fig. 3. Effect of repeated treatment with amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), morphine, or nicotine on
the emission of 50-kHz ultrasonic vocalizations (USVs). Rats received ﬁve drug administrations on either consecutive or alternate
days. Each rat was administered only one given drug. USVs were recorded during the ﬁrst and ﬁfth drug administrations. *p<0.05
compared with vehicle-treated rats. #p<0.05 compared with morphine-treated rats. adm.=administration.
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amphetamine on alternate days emitted signiﬁcantly
more 50-kHz USVs compared with vehicle-treated rats
(t=2.31, df=10, p=0.04) (Fig. 4a).
Amphetamine challenge (2mg/kg, i.p.), administered
after test cage re-exposure, elicited a signiﬁcantly
higher 50-kHz USVs emission compared with vehicle
challenge. Student’s t test revealed this effect for
both rats treated with amphetamine on consecutive
(t=4.78, df=10, p=0.01), and alternate days (t=4.49,
df=10, p=0.01) (Fig. 4b). However, amphetamine chal-
lenge failed to further elevate 50-kHz USVs emission
compared with previous amphetamine treatments
(Supplementary Table S2).
MDMA
Rats repeatedly administered MDMA on consecutive
days showed a 50-kHz USVs emission comparable with
vehicle-treated rats, on test cage re-exposure 7 d after
treatment discontinuation. Conversely, rats repeatedly
administered MDMA on alternate days emitted more
50-kHz USVs than vehicle-treated rats when re-exposed
to the test cage (t=2.15, df=11, p=0.04) (Fig. 4a).
Rats challenged with MDMA (7.5mg/kg, i.p.) after
test cage re-exposure emitted 50-kHz USVs similar to
vehicle-challenged rats, although a trend towards an in-
crease in this effect was present in rats treated with
MDMA on alternate days (Fig. 4b). MDMA challenge
did not further elevate 50-kHz USVs emission compared
with previous MDMA treatments (Supplementary
Table S2).
Morphine
On test cage re-exposure 7 d after treatment discontinu-
ation, rats repeatedly treated with morphine on con-
secutive days showed a 50-kHz USVs emission not
signiﬁcantly different from that of vehicle-treated rats,
although a trend towards an increase in this effect was
observed. Conversely, rats repeatedly treated with mor-
phine on alternate days emitted signiﬁcantly more
50-kHz USVs than vehicle-treated rats on test cage
re-exposure (t=2.69, df=12, p=0.02) (Fig. 4a).
Challenge with morphine (7.5 mg/kg, s.c.) after test
cage re-exposure, stimulated an emission of 50-kHz
USVs similar to that elicited by vehicle challenge, irres-
pective of the previous morphine administration protocol
(Fig. 4b). Morphine challenge failed to further elevate
50-kHz USVs compared with previous morphine treat-
ments (Supplementary Table S2).
Nicotine
Rats repeatedly administered nicotine on consecutive
days showed a 50-kHz USVs emission comparable with
that of vehicle-treated rats, on test cage re-exposure 7 d
after treatment discontinuation. Similar results were
observed in rats receiving repeated nicotine on alternate
days, although the difference with vehicle-treated rats
was close to signiﬁcance (p=0.07) (Fig. 4a).
Challenge with nicotine (0.4 mg/kg, s.c.), administered
after test cage re-exposure, elicited a 50-kHz USVs emis-
sion comparable with that stimulated by vehicle
challenge, irrespective of the previous nicotine adminis-
tration protocol (Fig. 4b). Nicotine challenge did not
further elevate 50-kHz USVs compared with previous
nicotine treatments (Supplementary Table S2).
Time-course of drug-stimulated 50-kHz USVs during
repeated administration and challenge
Time-course analysis of drug-stimulated 50-kHz
USVs during repeated treatment revealed signiﬁcant time-
point differences between amphetamine- and vehicle-
treated rats. No differences with vehicle-treated rats were
found for the other drugs evaluated. Three-way ANOVA
for consecutive-day amphetamine revealed signiﬁcant
effects of treatment (F1,20 =10.16, p=0.01), time (F5,100=
2.40, p=0.04), and treatment× time interaction (F1,20=2.42,
p=0.02). Effects of day, treatment×day interaction, and
treatment×day×time interaction were not signiﬁcant.
Three-way ANOVA for alternate-day amphetamine
showed signiﬁcant effects of treatment (F1,20=16.77,
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3,4-methylenedioxymethamphetamine (MDMA), morphine, or
nicotine. Rats treated on either consecutive or alternate days
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p=0.01), time (F5,100=2.31, p=0.04), day×time interaction
(F1,20=6.50, p=0.01), and treatment×day×time interaction
(F15,100 =5.64, p=0.01). Effects of day, and treatment×day
interaction were not signiﬁcant. Time-point differences
revealed by Tukey’s post-hoc test are reported in Fig. 5.
Similar results were obtained for the time-course of
50-kHz USVs stimulated by drug challenge, with amphe-
tamine being the only drug that displayed signiﬁcant
time-point differences compared with vehicle, as shown
by two-way ANOVA. Moreover, two-way ANOVA com-
parisons followed by Tukey’s post-hoc test revealed sign-
iﬁcant time-point differences between amphetamine
challenge and previous amphetamine administrations,
with a shift in the maximal number of 50-kHz USVs emit-
ted to earlier time points over the course of treatment
(Fig. 5). This effect was observed for both continuous
and alternate amphetamine administration.
Emission of 50-kHz USVs on repeated re-exposure
to the drug-paired environment
Amphetamine
Rats administered amphetamine, on either consecutive or
alternate days, displayed 50-kHz USVs emissions com-
parable with vehicle-treated rats on repeated test cage
re-exposure, starting 7 d after amphetamine challenge.
No differences in this effect were observed between rats
treated with amphetamine on consecutive or alternate
days (Fig. 6a, Supplementary Table S1).
MDMA
Rats administered MDMA, on either consecutive or
alternate days, showed 50-kHz USVs emissions similar
to vehicle-treated rats on repeated test cage re-exposure,
starting 7 d after MDMA challenge. This effect was
similar between rats on consecutive- and alternate-day
MDMA treatment (Fig. 6b, Supplementary Table S1).
Morphine
Rats administered morphine on consecutive days
displayed an emission of 50-kHz USVs not signiﬁcantly
different from vehicle-treated rats on repeated test cage
re-exposure, starting 7 d after morphine challenge. Never-
theless, morphine-treated rats displayed a trend towards
higher vocalization on the ﬁrst re-exposure (Fig. 6c).
Conversely, rats treated with morphine on alternate
days showed a 50-kHz USVs emission different from
that of vehicle-treated rats. Two-way ANOVA revealed
an effect of treatment (F1,12 =4.77, p=0.04) and an effect
of day (F1,12 =6.00, p=0.04), but no treatment×day interac-
tion (F1,12 =1.6, p=0.23). Tukey’s post-hoc test indicated
that morphine-treated rats exhibited signiﬁcantly more
vocalizations on the ﬁrst re-exposure to the test cage
(Fig. 6c).
Moreover, two-way ANOVA indicated an effect of day
(F1,14=9.18, p=0.01), but no effect of treatment (F1,14 =0.48,
p=0.49), and no treatment×day interaction (F1,14=3.18,
p=0.09) when the 50-kHz USVs emissions on repeated
test cage re-exposure were compared between rats admin-
istered morphine on consecutive and alternate days
(Fig. 6c).
Nicotine
Rats administered nicotine, on either consecutive or alter-
nate days, showed 50-kHz USVs emissions not signiﬁ-
cantly different from that of vehicle-treated rats on
repeated test cage re-exposure, starting 7 d after nicotine
challenge. Moreover, rats treated with nicotine on con-
secutive days displayed a 50-kHz USVs emission similar
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to that of rats on alternate-day administration (Fig. 6d,
Supplementary Table S1).
Emission of 50-kHz USVs following drug
administration and test cage re-exposure in rats treated
with morphine in the home cage
In this study, rats administered morphine on alternate
days displayed the most pronounced and long-lasting
50-kHz USVs emission on test cage re-exposure. There-
fore, to ascertain the conditioned nature of these vocaliz-
ations, a group of rats that received morphine in the home
cage was later exposed to the test cage, and the emission
of 50-kHz USVs evaluated. Rats received repeated mor-
phine (7.5 mg/kg, s.c., four administrations) in the home
cage (MHC rats), alternated with vehicle in the test cage
every other day. When given a ﬁfth morphine adminis-
tration in the test cage, MHC rats displayed a modest
drug-stimulated 50-kHz USVs emission, similar to that
observed in rats repeatedly treated with either vehicle
(t=0.51, df=10, p=0.62) or morphine in the test cage
(MTC rats) on alternate days (t=0.96, df=12, p=0.36)
(Fig. 7a). MHC rats emitted a low number of 50-kHz
USVs on test cage re-exposure 7 d after drug discontinu-
ation, immediately before morphine challenge. This effect
was comparable with that observed in vehicle-treated rats
(t=0.39, df=10, p=0.71), but signiﬁcantly lower than that
observed in MTC rats (t=2.32, df=12, p=0.04) (Fig. 7b).
Following a challenge with morphine (7.5 mg/kg, s.c.)
in the test cage, MHC rats displayed a scarce vocaliza-
tion, which was similar to that recorded from either
Amphetamine
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MHC=morphine in home cage; MTC=morphine in test cage.
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vehicle-treated (t=1.14, df=10, p=0.29) or MTC rats
(t=1.12, df=12, p=0.28) (Fig. 7a). Finally, MHC rats
showed a vocalization similar to that of vehicle-treated
rats on repeated test cage re-exposure (data not shown).
Emission of ‘trill’ 50-kHz USVs following drug
administration on alternate days and re-exposure to
the drug-paired environment
Table 2 summarizes the changes in the numbers and per-
centages of ‘trill’ 50-kHz USVs recorded during repeated
treatment on alternate days with amphetamine, MDMA,
morphine, or nicotine, re-exposure to the test cage and
drug challenge, and repeated test cage re-exposure.
Repeated treatment and challenge with amphetamine
(2mg/kg, i.p.) were the only conditions that elevated
the number of ‘trill’ 50-kHz USVs, compared with
repeated vehicle administration. Two-way ANOVA indi-
cated a signiﬁcant effect of treatment (F1,10=9.44, p=0.02),
but no effect of day (F1,10 =3.51, p=0.06), and no treat-
ment×day interaction (F1,10=3.52, p=0.06). Moreover,
t test revealed a signiﬁcant effect of amphetamine
challenge 7 d after drug discontinuation (t=3.03, df=10,
p=0.01). All the other changes observed in the numbers
and percentages of ‘trill’ 50-kHz USVs did not reach stat-
istical signiﬁcance (Supplementary Tables S3 and S4). The
time-course of ‘trill’ 50-kHz USVs was similar to that of
the total 50-kHz USVs, but no signiﬁcant modiﬁcations
were observed (data not shown).
Discussion
The present study evaluates the direct and long-lasting
effects of repeated administration of amphetamine,
MDMA, morphine, or nicotine on 50-kHz USVs. The
results obtained demonstrate that amphetamine was the
only drug to signiﬁcantly stimulate 50-kHz USVs. On
the other hand, all but nicotine-treated rats displayed
a higher 50-kHz USVs emission than vehicle-treated
rats when re-exposed to the drug-paired environment.
Finally, the analysis of ‘trill’ 50-kHz USVs revealed sign-
iﬁcant effects only for amphetamine. This study further
demonstrates that psychoactive drugs differ in their ef-
fects on 50-kHz USVs, and may help to understand the
relevance and usefulness of these vocalizations in the
study of the effects of drugs of abuse.
Drug-stimulated USVs
By showing that amphetamine was the only drug to sign-
iﬁcantly stimulate 50-kHz USVs during repeated admin-
istration and challenge, this study extends previous data
on acute drug effects (Sadananda et al., 2012; Simola
et al., 2012; Wright et al., 2012), and demonstrates that
Table 2. Emission of ‘trill’ 50-kHz ultrasonic vocalizations (USVs). The upper panel reports the drug-stimulated ‘trill’ USVs measured
during repeated treatment with amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), morphine, or nicotine, and drug
challenge. The lower panel reports the ‘trill’ USVs measured before the administration of drug challenge, and during repeated test cage
re-exposure
Emission of ‘trill’ 50-kHz USVs on repeated drug treatment and challenge
Treatment
First administration Fifth administration Challenge
Number Perc. Number Perc. Number Perc.
Amphetamine 109.7±41.9* 9.6±3.2 27±13.6* 5.2±3.0 49.8±16.4* 5.6±2.5
MDMA 1.7±0.9 6.9±3.6 0.1±0.1 0.5±0.5 0±0 0±0
Morphine 0.1±0.1 2.1±2.1 2.3±1.3 3.1±1.2 0.1±0.1 0.2±0.2
Nicotine 0±0 0±0 0±0 0±0 0±0 0±0
Vehicle 0.3±0.2 3±2.1 0.5±0.5 0.5±0.5 0.2±0.2 0.3±0.3
Emission of ‘trill’ 50-kHz USVs on re-exposure to the drug-paired environment
Treatment
Challenge day First repeated re-exp. Fifth repeated re-exp.
Number Perc. Number Perc. Number Perc.
Amphetamine 3±1.2 3.9±2.5 0.3±0.3 0.4±0.4 1.7±1.7 1.4±1.4
MDMA 2.9±2.5 1.9±1.4 0.2±0.2 1.5±1.5 1.7±0.8 4.1±2.2
Morphine 8.5±4.4 3.7±1.5 5.1±2.2 5.5±1.7 3±1.2 6.5±2.4
Nicotine 0±0 0±0 0.2±0.2 2.1±2.1 0±0 0±0
Vehicle 0.7±0.7 1.6±1.6 0.3±0.2 1.3±1.1 0.2±0.2 1.3±1.3
MDMA=3,4-methylenedioxymethamphetamine. perc.=percentage; re-exp=re-exposure.
* p<0.05 compared with vehicle-treated rats.
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MDMA, morphine, and nicotine fail to elicit 50-kHz
USVs, even after repeated administration. This ﬁnding
might be explained by the different mechanisms of action
of the drugs evaluated, with emphasis on the modulation
of dopamine (DA) transmission. Previous investigations
have shown that stimulation of DA receptors in the
nucleus accumbens (NAc) shell is crucial for 50-kHz
USVs emission (Burgdorf et al., 2001, 2007; Wintink and
Brudzynski, 2001; Thompson et al., 2006). The drugs
evaluated in this study may all increase DA in the NAc
shell, but whereas amphetamine directly elevates DA
levels, MDMA, morphine, and nicotine elicit a weaker ef-
fect, and act through indirect mechanisms (Di Chiara and
Imperato, 1988; Cadoni et al., 2005; Kleijn et al., 2011).
Moreover, it is noteworthy that, at least for morphine
and nicotine, repeated drug administration has been
found to weaken, rather than sensitize, DA release in
the NAc shell (Cadoni and Di Chiara, 1999, 2000).
Finally, it is known that neurotransmitters other than
DA may modulate 50-kHz USVs emission (Fu and
Brudzynski, 1994; Wright et al., 2012), and that the
drugs evaluated in this study can interact with these neu-
rotransmitters (Kalivas, 2007). Therefore, the discrepan-
cies in drug-stimulated 50-kHz USVs observed in this
study could be explained by the different modulation of
both DA and non-dopaminergic neurotransmitters by
the drugs evaluated, although other mechanisms cannot
be ruled out (see Simola et al., 2012 for a discussion).
Based on the hypothesis that 50-kHz USVs may indi-
cate hedonia and positive affect (Knutson et al., 2002;
Burgdorf et al., 2011), and considering that drugs of
abuse target reward circuits and produce sensitization
to some of their effects (Vanderschuren and Kalivas,
2000; Di Chiara et al., 2004), a progressive increase in
50-kHz USVs during the drug treatments in this study
would have been expected. In line with earlier investi-
gations (Hamed et al., 2012; Wright et al., 2012), this effect
was observed for morphine, as the emission of 50-kHz
USVs was greater on the ﬁfth than on the ﬁrst drug
administration. However, rather than sensitization, this
ﬁnding indicates tolerance to morphine-induced inhi-
bition of 50-kHz USVs (Simola et al., 2012; Wright et al.,
2012), as the number of vocalizations recorded on the
ﬁfth drug administration was similar to that of vehicle-
treated rats. Similar, but not signiﬁcant, modiﬁcations
in 50-kHz USVs emission were observed within
nicotine-treated rats, whereas rats administered MDMA
on alternate days displayed a trend towards an increase
in vocalization upon drug challenge.
To further clarify the signiﬁcance of drug-stimulated
50-kHz USVs, it is interesting to compare these results
with those of amphetamine-treated rats. Thus, ampheta-
mine robustly stimulated 50-kHz USVs, but no modiﬁ-
cations in the total number of vocalizations emitted
were observed during repeated drug administration and
challenge. Interestingly, this ﬁnding is in line with re-
cent data showing that rats repeatedly treated with
amphetamine did not substantially develop a sensitized
50-kHz USVs emission, and that no sensitization of
50-kHz USVs occurred in rats that self-administered
methamphetamine (Taracha et al., 2012; Mahler et al.,
2013). However, it is noteworthy that time-course analy-
sis of amphetamine-stimulated 50-kHz USVs revealed a
shift in the peak effect over drug treatment and challenge,
which appears in line with earlier studies showing a sen-
sitized emission of 50-kHz USVs following repeated ad-
ministration of psychostimulants (Ahrens et al., 2009;
Mu et al., 2009). Taken together, the results of the present
study may suggest that, even though the evidence linking
50-kHz USVs with positive affect and reward is rather
solid, the 50-kHz USVs observed after the administration
of a drug could indicate not only drug-mediated reward,
but also other effects. It can be hypothesized that drug-
stimulated 50-kHz USVs may reﬂect, to some extent,
behavioral activation and/or hyperstimulation of the
dopaminergic system. This view would ﬁt with data
from the present and previous studies showing that
dopaminergic drugs are most effective in eliciting
50-kHz USVs (Mu et al., 2009; Williams and Undieh,
2010; Wright et al., 2010, 2012; Brudzynski et al., 2012;
Simola et al., 2012). In this regard, it is noteworthy that,
even though DA is critical for the reinforcing properties
of drugs (Di Chiara and Bassareo, 2007), elevations in
DA levels, which may trigger 50-kHz USVs (Thompson
et al., 2006), may not necessarily be indicative of a
drug-induced positive affective state (Berridge and
Robinson, 1998; Ikemoto, 2010).
USVs emitted on re-exposure to the test cage
A major ﬁnding of this study is that treatment with drugs
that fail to directly stimulate 50-kHz USVs may induce
long-lasting vocalizations upon re-exposure to the en-
vironment where the drug was administered. Thus,
when rats were re-exposed to the test cage, 50-kHz
USVs were emitted not only by amphetamine-treated
rats, which vocalized following drug administrations,
but also by rats that received MDMA or morphine,
which did not. A possible explanation of these vocaliza-
tions may rely in the conditioning effects of the drugs
evaluated. This is suggested by the ﬁnding that rats trea-
ted with morphine in the home cage, alternated with ve-
hicle in the test cage, scarcely vocalized on test cage
re-exposure. Further support to this view comes from
the evidence that drug-treated rats displayed a higher
spontaneous locomotor activity than vehicle-treated rats
when re-exposed to the test cage, which could indicate
drug-induced environmental conditioning. Interestingly,
morphine-treated rats displayed a most pronounced and
persistent 50-kHz USVs emission following test cage
re-exposure, as this effect was still detectable 7 d after
the last drug challenge, which appears in line with the
ability of opiates to induce persistent conditioned
responses (Nielsen and Kreek, 2012). At variance with
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this, when re-exposed to the test cage, nicotine-treated
rats exhibited a 50-kHz USVs emission not signiﬁcantly
different from that of vehicle-treated rats, likely attribu-
table to a marked interindividual variability in this effect
within and between the experimental groups.
The vocalization by amphetamine-treated rats
re-exposed to the drug-paired environment observed in
this study is in line with previous evidence (Knutson
et al., 1999). On the other hand, some earlier studies,
but not others, have reported conditioned 50-kHz USVs
in morphine-treated rats re-exposed to a drug-paired en-
vironment (Knutson et al., 1999; Hamed et al., 2012;
Wright et al., 2012). These discrepancies could be attribu-
table to confounding factors, such as interindividual
variability in vocalization rate, and differences in rat
strain and drug-administration protocols. The present
study evaluates, for the ﬁrst time, the 50-kHz USVs emis-
sions induced by different drugs of abuse under the same
experimental conditions, and allows direct comparison of
the effects of these drugs. Therefore, the present results
suggest that 50-kHz USVs may be a valuable tool to in-
vestigate the long-lasting and conditioning effects of
drugs, as they provide new evidence supporting the abil-
ity of amphetamine and morphine to elicit 50-kHz USVs
following re-exposure to a drug-paired environment, and
extend this ﬁnding to MDMA.
‘Trill’ USVs emission
Previous investigations have suggested that the ‘trill’ sub-
type of 50-kHz USVs may be a selective indicator of posi-
tive affect, as a sustained emission of these vocalizations
has been reported in rats exposed to pleasurable stimuli,
such as homospeciﬁc and heterospeciﬁc social contacts
(tickling), or amphetamine administration (Burgdorf
et al., 2008; Ahrens et al., 2009; Wright et al., 2010). In
the present study, amphetamine was the only drug that
elicited a signiﬁcant emission of ‘trill’ vocalizations.
Interestingly, the number of ‘trill’ 50-kHz USVs emitted
did not undergo sensitization, but rather decreased dur-
ing repeated amphetamine treatment. This seems in con-
trast with a previous study that observed sensitization of
‘trill’ 50-kHz USVs in rats repeatedly administered
amphetamine (Ahrens et al., 2009). Again, this discrep-
ancy is likely attributable to methodological issues, as
the rat strain, the duration of the recording time, and
the criteria used to classify ‘trill’ 50-kHz USVs.
Nevertheless, and most importantly, the present results
are in agreement with other studies that failed to observe
a sensitized ‘trill’ 50-kHz USVs emission during either ac-
quisition of morphine-induced conditioned place prefer-
ence or methamphetamine self-administration (Wright
et al., 2012; Mahler et al., 2013). The lack of a sensitized
‘trill’ 50-kHz USVs emission by amphetamine-treated
rats might challenge the hypothesis that these vocaliza-
tions are selectively linked to hedonia. However, it is con-
ceivable that, similar to observations in this study for the
total 50-kHz USVs, the presence/absence of ‘trill’ vocali-
zations after the administration of a drug may indicate ef-
fects not necessarily, or exclusively, related to the hedonic
properties of the drug. It is noteworthy that this study
observed ‘trill’ 50-kHz USVs upon test cage re-exposure
in all but nicotine-treated rats, although changes involv-
ing these vocalizations never reached signiﬁcance.
Role of the administration protocol on USVs emission
The present study observed a similar pattern of drug-
stimulated 50-kHz USVs between consecutive- and
alternate-day administration, and this effect was evident
for all the drugs evaluated. On the other hand, rats on
alternate-day administration displayed a more marked
vocalization when re-exposed to the test cage after drug
discontinuation. Previous studies have suggested that
the emission of 50-kHz USVs on re-exposure to a drug
paired environment may indicate drug expectation in
rats (Knutson et al., 2002; Ma et al., 2010; Maier et al.,
2010). Moreover, experiments with cocaine have shown
that drug expectation is increased in rats subjected to an
intermittent protocol of substance administration (Puig
et al., 2012), and that rats self-administering cocaine dis-
played a boost in the emission of 50-kHz USVs when
re-exposed to cocaine-paired cues after a weekend of
drug abstinence (Maier et al., 2010). Therefore, it can be
hypothesized that rats on alternate-day treatment may ex-
perience a more pronounced drug expectation than rats
on consecutive-day treatment. This, in turn, could justify
why the former rats displayed a more marked 50-kHz
USVs emission upon test cage re-exposure. It is note-
worthy that this effect appeared to be long-lasting in
rats treated with morphine, and that opiates are known
to induce intense craving, which can persist long after
drug discontinuation (NIDA, 2005). Therefore, the results
of the present study may suggest that the intensity and/or
resistance to extinction of 50-kHz USVs emitted on
re-exposure to a drug-paired environment may be linked
to drug craving, and that these vocalizations could be
useful for studying drug seeking. However, further and
more detailed investigations of the factors (e.g. drug
dose and duration of administration) and of the drug-
paired cues (e.g. environmental vs. introceptive) that are
able to promote vocalizations are warranted to validate
this hypothesis.
Conclusions
By evaluating different psychoactive drugs under com-
parable conditions, and so avoiding confounding factors
related to the experimental procedure, the present study
extends our previous ﬁndings and demonstrates that
MDMA, morphine, and nicotine fail to stimulate 50-kHz
USVs, even after repeated administration. Moreover, this
study shows that drugs may have different direct and
long-lasting effects on 50-kHz USVs. In fact, drugs that
do not elicit 50-kHz USVs directly after administration,
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such as morphine and MDMA, are nevertheless able
to induce vocalizations in rats that are re-exposed to
an environment paired with drug administration,
which are likely dependent on the drugs’ conditioning
properties. Based on the results obtained, we suggest
that 50-kHz USVs can be useful to evaluate the long-
lasting effects and conditioning properties of psychoac-
tive drugs, rather than their direct acute effects.
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